Silica xerogel as an implantable carrier for controlled drug delivery—evaluation of drug distribution and tissue effects after implantation
- 22 November 1999
- journal article
- Published by Elsevier in Biomaterials
- Vol. 21 (2) , 193-198
- https://doi.org/10.1016/s0142-9612(99)00148-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrierBiomaterials, 1997
- Effect of sintering temperature on silica gels and their bone bonding abilityBiomaterials, 1995
- Targeting TGF–β for treatment of diseaseNature Medicine, 1995
- Biodistribution and Scintigraphy of11C-Toremifene in Rats Bearing DMBA-Induced Mammary CarcinomaBasic & Clinical Pharmacology & Toxicology, 1989
- A new triphenylethylene compound, Fc-1157aCancer Chemotherapy and Pharmacology, 1986
- The use of porous and surface modified silicas as drug delivery and stabilizing agentsDrug Development and Industrial Pharmacy, 1983
- Toxicology and biocompatibility of bioglassesJournal of Biomedical Materials Research, 1981
- The role of the fibrous capsule in the function of implanted drug‐polymer sustained release systemsJournal of Biomedical Materials Research, 1981
- Murine immunological and histological changes in response to chronic silica exposureEnvironmental Research, 1980
- AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGESThe Journal of Experimental Medicine, 1966